vimarsana.com
Home
Live Updates
Lumos Receives US FDA Clearance for FebriDx® : vimarsan
Lumos Receives US FDA Clearance for FebriDx® : vimarsan
Lumos Receives US FDA Clearance for FebriDx®
MELBOURNE, Australia, July 3, 2023 /PRNewswire/ — Lumos Diagnostics (ASX: LDX), ("Lumos" or the "Company") a leader in rapid, point-of-care (POC)...
Related Keywords
Canada ,
Melbourne ,
Victoria ,
Australia ,
Turkey ,
Brazil ,
Singapore ,
Malaysia ,
United Kingdom ,
Pakistan ,
United States ,
South Melbourne ,
Matthijs Smith ,
Centers For Disease ,
Company Registered Office ,
Lumos Diagnostics Holdings Ltd ,
Lumos Disclosure Committee ,
Drug Administration ,
Lumos Diagnostics ,
Disease Control ,
Outpatient Antibiotic Stewardship ,
Doug Ward ,
Lumos Disclosure ,
Registered Office ,